HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serial studies of protein C and its plasma inhibitor in patients with disseminated intravascular coagulation.

Abstract
This study was undertaken to determine the levels of protein C antigen and activity and protein C inhibitor in sequential plasma samples of disseminated intravascular coagulation (DIC) patients. Our normal range for both protein C antigen and activity is 70 to 130 U/dL, and protein C inhibitor is 65 to 135 U/dL. A decreased level of protein C activity was found in 96% of the plasma samples from individuals with DIC; the protein C antigen was decreased in 73%. The inhibitor of protein C was decreased in all samples. Analysis of serial samples from patients with DIC reveals that protein C activity and antigen and protein C inhibitor decrease progressively during the initial stages of DIC and remain at a low level for 24 to 48 hours before gradually returning toward normal in nonfatal cases. The protein C activity decreases in parallel with protein C inhibitor and is lower than protein C antigen. In a fatal case of DIC, protein C activity and protein C inhibitor rapidly decreased to undetectable levels; however, protein C antigen was gradually decreasing but still detectable at time of death. In DIC, a discrepancy initially occurs between the activity and antigen of protein C, suggesting a complex with the inhibitor or other inactive forms of protein C. Protein C appears to play a major role in the control of DIC.
AuthorsR A Marlar, J Endres-Brooks, C Miller
JournalBlood (Blood) Vol. 66 Issue 1 Pg. 59-63 (Jul 1985) ISSN: 0006-4971 [Print] United States
PMID3924142 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Blood Coagulation Factors
  • Glycoproteins
  • Protein C
  • Factor V
  • Factor VIII
Topics
  • Blood Coagulation Factors (analysis)
  • Child
  • Disseminated Intravascular Coagulation (enzymology)
  • Factor V (analysis)
  • Factor VIII (analysis)
  • Female
  • Glycoproteins (antagonists & inhibitors, blood)
  • Humans
  • Leukemia, Myeloid, Acute (blood)
  • Male
  • Middle Aged
  • Pancreatic Neoplasms (blood)
  • Protein C
  • Sepsis (blood)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: